Navinta Appeals Infringement Ruling Over Naropin
In a notice filed Wednesday in the U.S. District Court for the District of New Jersey, Navinta said it was appealing to the U.S. Court of Appeals for the Federal Circuit. After a bench trial, Judge Joel A. Pisano ruled that Navinta's abbreviated new drug application infringed three Abraxis patents.
Navinta's notice states that it plans to file a motion to...
To view the full article, register now.